Polycystic ovary syndrome and COVID-19: An emerging risk factor
Main Author: | Shashank R Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Human Reproductive Sciences |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2021;volume=14;issue=2;spage=211;epage=212;aulast=Joshi |
Similar Items
-
The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2020-12-01) -
Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
Polycystic ovary syndrome and risk factors for gestational diabetes
by: Sanna Mustaniemi, et al.
Published: (2018-06-01) -
Cardiovascular and Inflammatory Risk Factors in Polycystic Ovary Syndrome
by: Blair, S. A.
Published: (2010)